Cyclacel Pharmaceuticals ... (CYCC)
0.33
-0.00 (-0.45%)
At close: Mar 03, 2025, 12:20 PM
Cyclacel Pharmaceuticals Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 |
| Net Income | -22.55M | -21.2M | -18.89M | -8.45M | -7.83M | -7.29M | -7.47M | -11.79M | -14.34M | -19.39M | -10.15M | -13.19M | -15.24M | -16.02M | -19.57M | -40.38M | -24.05M | -29.26M | -29.42M | -39.59M | -18.46M |
| Depreciation & Amortization | 31K | 32K | 43K | 20K | 20K | 29K | 32K | 133K | 210K | 174K | 70K | 60K | 241K | 457K | 668K | 1.86M | 299K | 1.09M | 1.55M | 1.31M | 929K |
| Stock-Based Compensation | 1.47M | 1.51M | 1.16M | 430K | 466K | 331K | 266K | 782K | 745K | 1.22M | 357K | 380K | 882K | 1.75M | 810K | 1.7M | n/a | n/a | 2.2M | 2.2M | n/a |
| Other Working Capital | 4.42M | -3.74M | -3.76M | 31K | 143K | -327K | 1.23M | 439K | 342K | -1.03M | -1.2M | -239K | 174K | 516K | 1.72M | -969K | 878K | -5.42M | -1.78M | 921K | -25K |
| Other Non-Cash Items | 227K | -967K | -1.49M | 347K | -38K | -165K | 1.87M | 782K | 51K | 322K | -1.02M | -787K | -15.85M | 338K | 343K | 1.31M | -264K | 13.41M | 6.99M | 14.79M | 2.07M |
| Deferred Income Tax | n/a | 967K | 1.49M | -347K | n/a | n/a | n/a | -794K | n/a | n/a | -5.5M | -39K | 15.24M | -13K | 326K | 6.57M | n/a | n/a | -1.81M | -1.48M | n/a |
| Change in Working Capital | 4.71M | -1.17M | -853K | 61K | -2.06M | 227K | -308K | 809K | -1.12M | -1.03M | -1.95M | 1.53M | 751K | -2.55M | 2.23M | -969K | 878K | -5.42M | -1.03M | 1.67M | -25K |
| Operating Cash Flow | -16.11M | -20.83M | -18.54M | -7.93M | -9.45M | -6.7M | -7.48M | -10.08M | -14.46M | -18.7M | -18.2M | -12.04M | -13.98M | -16.04M | -15.19M | -29.91M | -23.14M | -20.17M | -21.51M | -21.09M | -15.49M |
| Capital Expenditures | -6K | -7K | -27K | -96K | -10K | -39K | -13K | -3K | -34K | -309K | -208K | -12K | -6K | -8K | -15K | -366K | -1.77M | -667K | -900K | -4.45M | -995K |
| Acquisitions | n/a | n/a | n/a | n/a | 38K | n/a | n/a | 12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.76M | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.06M | -153.6M | n/a | -52.29M | -79.98M | -30.54M |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.48M | 30.77M | 136.44M | 4.55M | 78.39M | 57.55M | 32.76M |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | 38K | n/a | n/a | 12K | 96K | 384K | 5.9M | 62K | 5K | 41K | 91K | n/a | n/a | 26K | 1.5M | n/a | n/a |
| Investing Cash Flow | -6K | -7K | -27K | -96K | 28K | -39K | -13K | 9K | 62K | 75K | 5.69M | 50K | -1K | 33K | 1.56M | 27.34M | -22.69M | 3.91M | 26.7M | -26.87M | 1.22M |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11K | -89K | -269K | 8.35M | -965K | 12.66M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | -201K | -201K | -201K | -201K | -201K | -201K | -201K | -200K | -201K | -200K | -305K | n/a | -364K | n/a | n/a | -1.23M | -1.22M | -921K | -1.22M | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | 4.57M | 4.54M | 4.05M | n/a | 200K | n/a | n/a | -21K | n/a | 94K | 3K | n/a | 314K | n/a | n/a | 15.96M | 1.22M | 3.31M | 33K |
| Financial Cash Flow | 848K | 3M | 21.74M | 29.5M | 3.85M | 429K | 14.75M | 6.59M | 10.86M | 12.2M | 27.33M | 3.98M | 8.91M | 33.4M | 3.85M | -1.24M | 32.21M | 57.4M | -5.49M | 59.62M | 12.78M |
| Net Cash Flow | -14.97M | -18.21M | 3.15M | 21.52M | -5.62M | -6.41M | 7.39M | -3.92M | -3.75M | -6.96M | 14.73M | -8.04M | -5.05M | 18M | -12.73M | -6.76M | -13.25M | 41.12M | -298K | 11.66M | -1.49M |
| Free Cash Flow | -16.12M | -20.83M | -18.57M | -8.03M | -9.46M | -6.74M | -7.49M | -10.08M | -14.49M | -19.01M | -18.41M | -12.05M | -13.98M | -16.05M | -15.21M | -30.27M | -24.91M | -20.84M | -22.41M | -25.53M | -16.48M |